Commerzbank Aktiengesellschaft’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-14,422
Closed -$77 1080
2016
Q2
$77 Sell
14,422
-3,442
-19% -$17.6K ﹤0.01% 973
2016
Q1
$82K Buy
17,864
+3,806
+27% +$15.3K ﹤0.01% 993
2015
Q4
$73K Buy
+14,058
New +$81.6K ﹤0.01% 1105
2014
Q3
Sell
-14,842
Closed -$171K 1252
2014
Q2
$171K Sell
14,842
-26,215
-64% -$239K ﹤0.01% 1149
2014
Q1
$411K Buy
41,057
+25,200
+159% +$364K ﹤0.01% 1025
2013
Q4
$247K Buy
+15,857
New +$218K ﹤0.01% 1293

Other funds holding RPTP

Commerzbank Aktiengesellschaft's RPTP Position: Q3 2016 in Review

Commerzbank Aktiengesellschaft sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 14,422 shares — an estimated $77 sold.

Commerzbank Aktiengesellschaft first reported a position in RPTP in Q4 2013 and held it in 6 quarters. The position peaked at $411K in Q1 2014. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Commerzbank Aktiengesellschaft reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 14,422 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $77.
  • Commerzbank Aktiengesellschaft first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 6 quarters.
  • Commerzbank Aktiengesellschaft's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $411K in Q1 2014.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2016, filed 14 Nov 2016.